ReviewFaculty reviews2021

Managing chronic lymphocytic leukemia in 2020: an update on recent clinical advances with a focus on BTK and BCL-2 inhibitors.

Prithviraj Bose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.